158 related articles for article (PubMed ID: 22533715)
1. Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009.
Snowden JA; Pearce RM; Lee J; Kirkland K; Gilleece M; Veys P; Clark RE; Kazmi M; Abinun M; Jackson GH; Mackinnon S; Russell NH; Cook G;
Br J Haematol; 2012 Jun; 157(6):742-6. PubMed ID: 22533715
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of hematopoietic stem cell transplantation for severe treatment-resistant autoimmune cytopenia in children.
Rabusin M; Snowden JA; Veys P; Quartier P; Dalle JH; Dhooge C; Di Bartolomeo P; Gonzalez-Vicent M; Gibson B; Iriondo A; Juergens H; Lisukov I; Messina C; Mialou V; Steward CG; Urban C; Renard M; Giurici N; Peters C; Badoglio M; Ronfani L; Dini G; Farge D; Saccardi R;
Biol Blood Marrow Transplant; 2013 Apr; 19(4):666-9. PubMed ID: 23253561
[TBL] [Abstract][Full Text] [Related]
3. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.
Passweg JR; Rabusin M; Musso M; Beguin Y; Cesaro S; Ehninger G; Espigado I; Iriondo A; Jost L; Koza V; Lenhoff S; Lisukov I; Locatelli F; Marmont A; Philippe P; Pilatrino C; Quartier P; Stary J; Veys P; Vormoor J; Wahlin A; Zintl F; Bocelli-Tyndall C; Tyndall A; Gratwohl A;
Br J Haematol; 2004 Jun; 125(6):749-55. PubMed ID: 15180864
[TBL] [Abstract][Full Text] [Related]
4. Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation.
Achini-Gutzwiller FR; Snowden JA; Corbacioglu S; Greco R;
Br J Haematol; 2022 Jul; 198(1):24-45. PubMed ID: 37655707
[TBL] [Abstract][Full Text] [Related]
5. Forty years of haematopoietic stem cell transplantation: a review of the Basel experience.
O'Meara A; Holbro A; Meyer S; Martinez M; Medinger M; Buser A; Halter J; Heim D; Gerull S; Bucher C; Rovo A; Kühne T; Tichelli A; Gratwohl A; Stern M; Passweg JR
Swiss Med Wkly; 2014 Feb; 144():w13928. PubMed ID: 24567259
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic SCT for patients with autoimmune diseases.
Daikeler T; Hügle T; Farge D; Andolina M; Gualandi F; Baldomero H; Bocelli-Tyndall C; Brune M; Dalle JH; Urban C; Ehninger G; Gibson B; Linder B; Lioure B; Marmont A; Matthes-Martin S; Nachbaur D; Schuetz P; Tyndall A; van Laar JM; Veys P; Saccardi R; Gratwohl A;
Bone Marrow Transplant; 2009 Jul; 44(1):27-33. PubMed ID: 19139739
[TBL] [Abstract][Full Text] [Related]
7. The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland.
Russell NH; Szydlo R; McCann S; Potter MN; Craddock C; Towlson K; Apperley JF;
Br J Haematol; 2004 Feb; 124(4):499-503. PubMed ID: 14984501
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
Chantry AD; Snowden JA; Craddock C; Peggs K; Roddie C; Craig JI; Orchard K; Towlson KE; Pearce RM; Marks DI;
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1310-7. PubMed ID: 17162213
[TBL] [Abstract][Full Text] [Related]
9. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation.
Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G;
Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
11. The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
Kako S; Izutsu K; Kato K; Kim SW; Mori T; Fukuda T; Kobayashi N; Taji H; Hashimoto H; Kondo T; Sakamaki H; Morishima Y; Kato K; Suzuki R; Suzumiya J;
Am J Hematol; 2015 Feb; 90(2):132-8. PubMed ID: 25382792
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune disease after autologous hematopoietic stem cell transplantation.
Bohgaki T; Atsumi T; Koike T
Autoimmun Rev; 2008 Jan; 7(3):198-203. PubMed ID: 18190878
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.
Abboud I; Porcher R; Robin M; de Latour RP; Glotz D; Socié G; Peraldi MN
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1251-7. PubMed ID: 19747632
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of fertility and pregnancy in autoimmune diseases after autologous haematopoietic stem cell transplantation.
Massenkeil G; Alexander T; Rosen O; Dörken B; Burmester G; Radbruch A; Hiepe F; Arnold R
Rheumatol Int; 2016 Nov; 36(11):1563-1568. PubMed ID: 27522225
[TBL] [Abstract][Full Text] [Related]
15. Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias.
Passweg JR; Rabusin M
Autoimmunity; 2008 Dec; 41(8):660-5. PubMed ID: 18958755
[TBL] [Abstract][Full Text] [Related]
16. Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Guillaume-Jugnot P; Badoglio M; Labopin M; Terriou L; Yakoub-Agha I; Martin T; Lioure B; Marjanovic Z; Blaise D; Nguyen S; Pugnet G; Huynh A; Deligny C; Seinturier C; Garban F; Swiader L; Bay JO; Braun T; de Latour RP; Rubio MT; Farge D
Clin Rheumatol; 2019 May; 38(5):1501-1511. PubMed ID: 30663016
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
Guillaume T; Beguin Y; Tabrizi R; Nguyen S; Blaise D; Deconinck E; Redjoul R; Cornillon J; Guillerm G; Contentin N; Sirvent A; Turlure P; Salmon A; Huynh A; François S; Peffault de Latour R; Yakoub-Agha I; Mohty M
Eur J Haematol; 2015 Mar; 94(3):265-9. PubMed ID: 25130897
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation for severe autoimmune diseases.
Gratwohl A
Autoimmunity; 2008 Dec; 41(8):673-8. PubMed ID: 18958760
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Gratwohl A; Brand R; Apperley J; Crawley C; Ruutu T; Corradini P; Carreras E; Devergie A; Guglielmi C; Kolb HJ; Niederwieser D;
Haematologica; 2006 Apr; 91(4):513-21. PubMed ID: 16533723
[TBL] [Abstract][Full Text] [Related]
20. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
